Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: An emerging dimorphic pathogen with reduced susceptibility to posaconazole

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1244-1248

  Khan, Zia U ^a   Ahmad, Suhail ^a   Brazda, Arnost ^b   Chandy, Rachel ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; POSACONAZOLE; VORICONAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FUNGAL DNA; TRIAZOLE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEBRIDEMENT; DRUG DOSE REDUCTION; FUNGAL GENETICS; FUNGUS ISOLATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MUCOR; MUCOR CIRCINELLOIDES; MUCORMYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; ZYGOMYCETES; ANTIFUNGAL RESISTANCE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; JAW DISEASE; MICROBIOLOGY; MOLECULAR GENETICS;

MUCOR CIRCINELLOIDES; ZYGOMYCETES;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; HUMANS; MALE; MAXILLARY DISEASES; MOLECULAR SEQUENCE DATA; MUCOR; SEQUENCE ANALYSIS, DNA; TRIAZOLES; ZYGOMYCOSIS;

EID: 65249120720     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02030-08     Document Type: Article

References (41)

1. Ahmad, S., Z. Khan, A. S. Mustafa, and Z. U. Khan. 2002. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J. Clin. Microbiol. 40:24832489.
2. Ahmad, S., M. Al-Mahmeed, and Z. U. Khan. 2005. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J. Med. Microbiol. 54:639-646.
3. Ahmad, S., Z. U. Khan, and A. M. Theyyathel. 2007. Value of Aspergillus terreus-specific DNA, (1-3) -β-D-glucan and galactomannan detection in serum and bronchoalveolar lavage specimens of experimentally infected mice. Diagn. Microbiol. Infect. Dis. 59:165-171.
4. Almyroudis, N. G., D. A. Sutton, A. W. Fothergill, M. G. Rinaldi, and S. Kusne. 2007. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob. Agents Chemother. 51:2587-2590.
5. Borman, A. M., C. J. Linton, S. J. Miles, and E. M. Johnson. 2008. Molecular identification of pathogenic fungi. J. Antimicrob. Chemother. 61 (Suppl. 1) : i7-i12.
6. Chandra, S., and A. Woodgyer. 2002. Primary cutaneous zygomycosis due to Mucor circinelloides. Australas. J. Dermatol. 43:39-42.
7. Chan-Tack, K. M., L. L. Nemoy, and E. N. Perencevich. 2005. Central venous catheter-associated fungemia secondary to mucormycosis. Scand. J. Infect. Dis. 37:925-927.
8. Chayakulkeeree, M., M. A. Ghannoum, and J. R. Perfect. 2006. Zygomycosis: the re-emerging fungal infection. Eur. J. Clin. Microbiol. Infect. Dis. 25:215-229.
9. Chopra, H., K. Dua, S. Bhatia, N. Dua, and V. Mittal. 13 August 2008, posting date. Invasive rhino-orbital fungal sinusitis following dental manipulation. Mycoses. [Epub ahead of print.]
10. Dannaoui, E., J. Meletiadis, J. W. Mouton, J. F. Meis, P. E. Verweij, and Eurofung Network. 2003. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J. Antimicrob. Chemother. 51:45-52.
11. Ferguson, T. D., S. D. Schniederjan, J. Dionne-Odom, M. E. Brandt, M. G. Rinaldi, F. S. Nolte, A. Langston, and S. M. Zimmer. 2007. Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes. J. Clin. Microbiol. 45:16481651.
12. 11a. Fetchick, R. J., M. G. Rinaldi, and S. H. Sun. 1986. Zygomycosis due to Mucor circinelloides, a rare agent of human fungal diseases, abstr. F-42, p. 404. Abstr. Annu. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
13. Fingeroth, J. D., R. S. Roth, J. A. Talcott, and M. G. Rinaldi. 1994. Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia. Clin. Infect. Dis. 19:135-137.
14. Greenberg, R. N., K. Mullane, J. A. van Burik, L. Raad, M. J. Abzug, G. Anstead, R. Herbrecht, A. Langston, K. A. Marr, G. Schiller, M. Schuster, J. R. Wingard, C. E. Gonzalez, S. G. Revankar, G. Corcoran, R. J. Kryscio, and R. Hare. 2006. Posaconazole as salvage therapy for zygomycosis. Antimicrob. Agents Chemother. 50:126-133.
15. Greenberg, R. N., L. J. Scott, H. H. Vaughn, and J. A. Ribes. 2004. Zygomycosis (mucormycosis) : emerging clinical importance and new treatments. Curr. Opin. Infect. Dis. 17:517-525.
16. Iwen, P. C, L. Sigler, R. K. Noel, and A. G. Freifeld. 2007. Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J. Clin. Microbiol. 45:636-640.
17. Kauffman C. A. 2004. Zygomycosis: reemergence of an old pathogen. 39: 588-590.
18. Khan, Z. U., S. Ahmad, E. Mokaddas, T. Said, M. P. Nair, M. A. Halim, M. R. Nampoory, and M. R. McGinnis. 2007. Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1→3) -beta-D-glucan in clinical specimens. J. Med. Microbiol. 56:129-132.
19. Khan, Z. U., S. Ahmad, E. Mokaddas, R. Chandy, J. Cano, and J. Guarro. 2008. Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie van Leeuwenhoek 94:343-352.
20. Kontoyiannis, D. P., M. S. Lionakis, R. E. Lewis, G. Chamilos, M. Healy, C. Perego, A. Safdar, H. Kantarjian, R. Champlin, T. J. Walsh, and I. I. Raad. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillusactive antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1360.
21. Kontoyiannis, D. P., and R. E. Lewis. 2006. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect. Dis. Clin. N. Am. 20:581-607.
22. Marty, F. M., L. A. Cosimi, and L. R. Baden. 2004. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N. Engl. J. Med. 350:950-952.
23. McIntyre, M., J. Baum, J. Arnau, and J. Nielsen. 2002. Growth physiology and dimorphism of Mucor circinelloides (syn. racemosus) during submerged batch cultivation. Appl. Microbiol. Biotechnol. 58:495-502.
24. Nagappan, V., and S. Deresinski. 2007. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clin. Infect. Dis. 45:1610-1617.
25. Palacio, A. D., M. J. Ramos, A. Perez, A. Arribi, I. Amondarian, S. Alonso, and Y. M. Cru Ortiz. 1999. Zigomicosis. Aprospito de cinco casos. Rev. Iberaom. Micol. 16:50-56.
26. Peel, T., J. Daffy, K. Thursky, P. Stanley, and K. Buising. 2008. Posaconazole as first line treatment for disseminated zygomycosis. Mycoses 51:542-545.
27. Pyrgos, V., S. Shoham, and T. J. Walsh. 2008. Pulmonary zygomycosis. Semin. Respir. Crit. Care Med. 29:111-120.
28. Ribes, J. A., C. L Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301.
29. Roden, M. M., T. E. Zaoutis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, M. Sein, T. Sein, C. C. Chiou, J. H. Chu, D. P. Kontoyiannis, and T. J. Walsh. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653.
30. Rogers, T. R. 2008. Treatment of zygomycosis: current and new options. J. Antimicrob. Chemother. 61 (Suppl. 1) :i35-i40.
31. Schwarz, P., S. Bretagne, J. C. Gantier, D. Garcia-Hermoso, O. Lortholary, F. Dromer, and E. Dannaoui. 2006. Molecular identification of zygomycetes from culture and experimentally infected tissues. J. Clin. Microbiol. 44:340-349.
32. Shindo, M., K. Sato, J. Jimbo, T. Hosoki, K. Ikuta, A. Sano, K. Nishimura, Y. Torimoto, and Y. Kohgo. 2007. Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia. Rinsho Ketsueki 48:412417. (In Japanese.)
33. Spellberg, B., J. Edwards, Jr., and A. Ibrahim. 2005. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin. Microbiol. Rev. 18:556-569.
34. Sugita, T., A. Nishikawa, R. Ikeda, and T. Shinoda. 1999. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J. Clin. Microbiol. 37:1985-1993.
35. Sun, Q. N., A. W. Fothergill, D. L. McCarthy, M. G. Rinaldi, and J. R. Graybill. 2002. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob. Agents Chemother. 46:1581-1582.
36. Tarrand, J. J., M. Lichterfeld, I. Warraich, M. Luna, X. Y. Han, G. S. May, and D. P. Kontoyiannis. 2003. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am. J. Clin. Pathol. 119:854-858.
37. Torres-Narbona, M., J. Guinea, J. Martínez-Alarcón, T. Peláez, and E. Bouza. 2007. In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob. Agents Chemother. 51:1126-1129.
38. Trifilio, S. M., C. L. Bennett, P. R. Yarnold, J. M. McKoy, J. Parada, J. Mehta. G. Chamilos, F. Palella, L. Kennedy, K. Mullane, M. S. Tallman, A. Evens, M. H. Scheetz, W. Blum, and D. P. Kontoyiannis. 2007. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 39:425-429.
39. van Burik, J. A., R. S. Hare, H. F. Solomon, M. L. Corrado, and D. P. Kontoyiannis. 2006. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin. Infect. Dis. 42:e61-e65.
40. Voigt, K., E. Cigelnik, and K. O'Donnell. 1999. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomalDNA sequence data. J. Clin. Microbiol. 37:3957-3964.
41. Wang, J. J., H. Satoh, H. Takahashi, and A. Hasegawa. 1990. A case of cutaneous mucormycosis in Shanghai, China. Mycoses 33:311-315.